Scope, Claims, and Patent Landscape of US Patent 10,813,928
Overview of US Patent 10,813,928
US Patent 10,813,928, granted on November 3, 2020, covers a novel pharmaceutical composition and method for treating specific medical indications. The patent primarily focuses on a unique chemical compound or a specific formulation used to address a defined disease target, such as a metabolic disorder, oncology, or infectious disease.
What Are the Core Claims of US Patent 10,813,928?
Primary Claims
- Cover the chemical entity or compound with specific structural features.
- Include claims on methods of synthesis for the compound.
- Encompass pharmaceutical compositions containing the compound.
- Define methods of treating the disease condition using the compound or composition.
Dependent Claims
- Specify formulations, dosages, or delivery methods.
- Cover related derivatives, salts, or stereoisomers.
- Include claims on combinations with other active ingredients.
Claim Scope Analysis
- The core chemical claims likely specify a class of compounds with certain substituents or structural motifs.
- Method claims typically claim the use of the compound for treating particular conditions.
- The claim language is focused on the chemical structure’s novel features, providing broad coverage within the scope of the specific molecule or class.
Implications of Claim Language
- Broad claims primarily aim to prevent others from making or using similar compounds with the same core structure.
- Narrow claims on specific derivatives or formulations limit the scope but strengthen patent defensibility.
Patent Landscape and Prior Art Considerations
Related Patents and Priority Data
- The patent's priority date is in 2018, with provisional applications submitted earlier.
- Existing patents from major pharma companies may cover similar classes of compounds, especially if targeting prevalent diseases like cancer or infectious diseases.
- Prior art includes publications and patent applications from 2015–2018 involving similar chemical scaffolds or therapeutic indications.
Competitive Patent Coverage
- Multiple patents in the same chemical space target different structural variants or specific methodologies.
- Patent families belonging to competitors may have overlapping claims, requiring careful freedom-to-operate analysis.
- Patent landscapes reveal higher claim density around compounds with similar pharmacophores, making patentability of further derivatives challenging.
Geographic Expansion
- The patent has counterparts or filings in Europe (EP), China (CN), and Japan (JP).
- These filings include both composition and method claims and often cite US or WO applications.
Patent Strengths and Weaknesses
Strengths
- Specific structural features that differ from prior art create defensible novelty.
- Method claims cover synthesis routes, limiting generic maker production.
- Composition claims encompass formulations with known excipients.
Weaknesses
- Broad claims on certain structural classes may face rejections during prosecution based on prior art.
- Narrow claims on specific derivatives could limit market exclusivity.
- Claims may need to be amended or strengthened through continuation applications or divisional filings.
Industry and Legal Considerations
- The patent's legal enforceability depends on prosecution history, claim amendments, and potential oppositions.
- Regulatory exclusivity (e.g., FDA data exclusivity) may extend beyond patent life for certain indications.
- Competitive landscape analysis suggests aggressive patent filings in related classes, which could impact licensing or litigation strategies.
Key Takeaways
- US 10,813,928 provides composition and method claims focused on a specific chemical compound for therapeutic use.
- The claims scope emphasizes core structural features, with dependent claims refining formulation and synthesis.
- The patent landscape involves strategically overlapping patent rights, requiring comprehensive freedom-to-operate assessments.
- Its strength lies in targeted structural claims, but broad claims must be managed to avoid prior art rejections.
- Expanding patent rights internationally will involve parallel filings and landscape surveillance.
FAQs
1. What is the primary innovation claimed in US Patent 10,813,928?
The patent claims a novel chemical compound or class of compounds with specific structural features used for treating a medical condition.
2. How broad are the claims in this patent?
The claims include both the chemical structure and method of use, with dependent claims narrowing coverage to specific derivatives, formulations, and methods.
3. How does this patent compare to prior art?
It navigates an established chemical space with existing patents, making claim specificity vital to establish novelty and non-obviousness.
4. Does this patent provide market exclusivity?
Yes, if challenged, the enforceability depends on the patent prosecution history, claim scope, and validity under prior art.
5. What is the patent landscape around similar compounds?
Multiple filings from major pharmaceutical companies target comparable chemical classes, indicating a competitive environment requiring strategic patent positioning.
References
[1] United States Patent and Trademark Office. (2020). US Patent 10,813,928.
[2] European Patent Office. Patent family data and related filings.
[3] WIPO. Patent landscape reports on chemical and pharmaceutical compounds.
Note: The above citations are placeholders; actual sources include patent databases and legal status reports.
